Kun Song

19PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSocial determinants of healthPhotonics, optoelectronics and optical communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 31, 2026
The prognostic value of surgery in patients with locally advanced vulvar cancer: results from the SEER database and a Chinese multicenter registry.

|Mar 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.

Yang Sun, Hongying Yang, Jing Wang

|Dec 21, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.

Xiaohua Wu, Jing Wang, Danbo Wang

|Jun 24, 2025
Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer.

Yanling Liu, Zhongshao Chen, Yan Duan

|Mar 03, 2025
Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer.

Zhuang Li, Penglin Liu, Aijun Yin

|Apr 01, 2024
The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.

Yuan Wei, Zhongshao Chen, Yingwei Li

Pageof 4

Frequent Collaborators

4 joint publications

Yingwei Li

3 joint publications

Ran Chu

3 joint publications

Zhongshao Chen

3 joint publications

Beihua Kong